Savings & support

Two women supporting each other

See how you can save on treatment and get support along the way.

Scroll Down
Down

Verzenio Continuous Care™ Program

Get support, savings, and help filling prescriptions from a dedicated team.

Personalized care that's here for you

The Verzenio Continuous Care Program gives you personalized support to help you have a positive experience while taking Verzenio.

Through 1-on-1 check-ins, your Verzenio Continuous Care team* can support you by:

3 simple ways to enroll

Mouse arrow pointing

Phone Icon

Call 1-844-VERZENIO
(1-844-837-9364)

Questions about Verzenio

Ask a member of your healthcare team about signing up

*Verzenio Continuous Care team is not made up of medical professionals. Your doctor is your source for medical advice.

Paying for treatment shouldn't be an additional concern for you and your loved ones, so we've created the Verzenio Savings Card † , which may help you manage treatment costs.

Verzenio Savings Card

Pay as little as $0 per month when eligible and commercially insured with coverage for Verzenio †

† Governmental beneficiaries excluded, terms and conditions apply. Click here to see the full terms and conditions.

Need a Savings Card?

By downloading a savings card, you are enrolling in Verzenio Continuous Care and therefore have access to its services.

Verzenio prescription

Filling Your Prescription

Here's how a specialty pharmacy works with you to fill your Verzenio prescription:

† Governmental beneficiaries excluded, terms and conditions apply. Click here to see the full terms and conditions.

Learn about Addressing Side Effects

Breast cancer support groups

There are many organizations that provide opportunities to connect in person or online for support. We've put together a list of support groups that can help you connect with other women who have breast cancer and share your experiences.

This information has been provided by the listed organizations, and Lilly is not responsible for the content. Its use on this site is not intended to serve as an endorsement of the listed organizations.

All third party organization names and other trademarks are the property of their respective trademark owners. Those trademark owners are not affiliated with Lilly and they do not sponsor or endorse this material.

BreastCancer.org

Breastcancer.org was founded 22 years ago and has become the leading digital resource for people facing the complex challenges of breast cancer diagnosis, treatment, and survivorship. Breastcancer.org uniquely uses excellence in program development and implementation to focus on helping people deal with the here-and-now questions and challenges they face by providing actionable, medically vetted information combined with a supportive digital peer community. It is critical that people have trustworthy information and guidance when considering life-changing choices about treatment and care, especially when urgent decisions need to be made. The education and support resources on Breastcancer.org — available at no cost in English and Spanish — serve an enormous purpose for people who count on access to reliable, relevant, easy-to-understand, and actionable guidance.

Cancer Support Community uplifts and strengthens people impacted by cancer by providing support, fostering compassionate communities and breaking down barriers to care through education, research, and advocacy. Its network of 190 locations includes CSC and Gilda's Club centers as well as hospital and healthcare partnerships. These locations, along with a helpline, online support communities, and award-winning education materials, provide free support services to patients, survivors, caregivers and families impacted by cancer.

Living Beyond Breast Cancer

Living Beyond Breast Cancer (LBBC) is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical and evidence-based content. 30 years since its inception, the organization remains committed to creating a culture of acceptance—where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope.

Share

SHARE Cancer Support is a national nonprofit that supports, educates, and empowers anyone who has been diagnosed with breast or gynecologic cancers, and provides outreach to the general public about signs and symptoms. They are a compassionate community of knowledgeable survivors, those living with cancer, and healthcare professionals. SHARE is dedicated to serving people of all races and cultures, backgrounds, and identities. Because no one should have to face breast, ovarian, uterine, cervical or metastatic breast cancer alone.

Verzenio Continuous Care can help connect you with advocacy groups and provide the support you need

Susan G. Komen

Susan G. Komen has a mission to save lives by meeting the most critical needs of the community and investing in breakthrough research to prevent and cure breast cancer. Their helpline provides emotional support, guidance, and information on breast health, breast cancer, local and national resources, as well as clinical trials. Additionally, Susan G. Komen offers support through Facebook groups, financial assistance, and resources to help you access the most up-to-date information on breast cancer risk factors, screening, diagnosis, treatment, metastatic breast cancer, survivorship, and more.

TOUCH, The Black Breast Cancer Alliance drives the collaborative efforts of patients, survivors, advocates, advocacy organizations, health care professionals, researchers, and pharmaceutical companies to work towards the common goal of eradicating Black Breast Cancer. TOUCH was founded on the vision that Black breast cancer patients deserve health parity, access to innovative treatments that are tested in their patient population, and increased representation in the breast cancer ecosystem. Founded and led by Black survivors who have experienced the marginalization and disenfranchisement of being Black in the breast cancer ecosystem, TOUCH fights every day to eradicate Black Breast Cancer—a disease with worse outcomes, fewer resources, and far less clinical research than its white counterpart. TOUCH's programs have been designed to support, empower, and equip Black women and their loved ones to and through Black Breast Cancer. From preventative breast health through diagnosis, from treatment through survivorship, TOUCH serves all Black women and families impacted by breast cancer.

Unite for HER (Helping to Empower and Restore) is a national nonprofit organization that supports those affected by breast and ovarian cancers. Its vision is that every person with breast and ovarian cancers will feel the support of a loving community, and will have access to comprehensive education, services, and tools that enrich their health and well-being. Unite for HER's comprehensive Wellness Programs provide members with free access to education, support, and integrative therapies and services like nutrition, yoga, Reiki, and more.

Young Survival Coalition

Young Survival Coalition (YSC) serves young adults diagnosed with breast cancer age 40 and under by providing tailored education, support and community programs to them and their caregivers.

Learn more about Verzenio as a treatment option for HR+, HER2– metastatic breast cancer

We will need your HIPAA authorization to work on your behalf to help you pay as little as possible. We believe that by you taking a little extra time now to provide HIPAA authorization, we can help you pay as little as possible for your Verzenio medication. Requesting a Verzenio savings card shouldn't take more than a few minutes. If you do not want to provide HIPAA authorization online, please contact The Verzenio Continuous Care Program at 1-844-Verzenio (1-844-837-9364) Mon-Fri, 8 am to 10 pm ET to request a savings card.

As a reminder, HIPAA is the Health Insurance Portability and Accountability Act that provides data privacy and security to protect your health information.

Terms and Conditions:

By enrolling in the Verzenio Savings Card Program ("Program") and using the Verzenio Savings Card ("Card"), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

Card Eligibility:

  1. You have been prescribed Verzenio ® (abemaciclib) consistent with FDA approved product labeling
  2. You are enrolled in a commercial drug insurance plan
  3. You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE ® /CHAMPUS, or any state prescription drug assistance program.
  4. You are a resident of the United States or Puerto Rico
  5. You are 18 years of age or older

Card Terms and Conditions

For patients with commercial drug insurance coverage for Verzenio: You must have commercial drug insurance that covers Verzenio and a prescription consistent with FDA-approved product labeling to pay as little as $0 for a 1-month prescription fill of Verzenio. Month is defined as 28-days. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges and separate maximum annual savings of up to $25,000 per calendar year. Participation in the Program requires a valid patient HIPAA authorization upon enrollment into the Program. Subject to Lilly USA, LLC's ("Lilly") right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2024.

Additional Program Terms and Conditions

If you have an insurance plan that is participating in an alternate funding program ("AFP") (examples include, but are not limited to, ImpaxRX, Payer Matrix, SHARx, Script Sourcing, and Paydhealth) that requires you to apply to the Verzenio Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of Verzenio, you are not eligible for and are prohibited from using the Verzenio Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member's use of Verzenio Savings Card Program. You agree to inform the Verzenio Savings Card Program if you are or become a member of such an alternative funding program. If at any time you begin receiving drug coverage under any state, federal, or government funded healthcare program, you understand that you will no longer be eligible for the Verzenio Savings Card and agree to call Lilly Support Services ™ for Verzenio ® at 1-800-LillyRx (1-800-545-5979) to stop participation. You are responsible for any applicable taxes, fees, and any amount that exceeds the monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly's sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason, including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for Verzenio, only allows partial coverage for Verzenio, removes coverage for Verzenio and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of Verzenio, or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for Verzenio. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. Card activation is required. No party may seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. By utilizing the Card, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you will notify your Insurance Carrier of your redemption of the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving Verzenio. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are nontransferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. The Card is not insurance. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Eligibility criteria, and terms and conditions for the Verzenio Savings Card Program may change from time to time; the most current version can be found at https://www.verzenio.lilly.com/savings-support. You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly's right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason, the Card expires and savings end on 12/31/2024.

TRICARE ® is a registered trademark of the Department of Defense (DoD), DHA.

Important Safety Information and Indication or Indications. Select to Expand. SAFETY SUMMARY INDICATIONS Important Safety Information and Indication or Indications. Select to Expand.

Important Safety Information. Select to Expand. SAFETY SUMMARY Important Safety Information. Select to Expand.

SAFETY SUMMARY

Warnings - Verzenio may cause serious side effects, including:

Diarrhea is common with Verzenio, may sometimes be severe and may cause dehydration or infection. The most common time to develop diarrhea is during the first month of Verzenio treatment. If you develop diarrhea during treatment with Verzenio, your healthcare provider may tell you to temporarily stop taking it, stop your treatment, or decrease your dose.

If you have any loose stools, start taking an antidiarrheal medicine (such as loperamide), drink more fluids, and tell your healthcare provider right away.

Low white blood cell counts (neutropenia) are common with Verzenio and may cause serious infections that can lead to death. Your healthcare provider should check your white blood cell counts before and during treatment. If you develop low white blood cell counts during treatment with Verzenio, your healthcare provider may tell you to temporarily stop taking it, decrease your dose, or wait before starting your next month of treatment. Tell your healthcare provider right away if you have signs and symptoms of low white blood cell counts or infections, such as fever and chills.

Verzenio may cause severe or life-threatening inflammation (swelling) of the lungs during treatment that can lead to death. If you develop lung problems during treatment with Verzenio, your healthcare provider may tell you to temporarily stop taking it, decrease your dose, or stop your treatment. Tell your healthcare provider right away if you have any new or worsening symptoms, including:

Verzenio can cause serious liver problems. Your healthcare provider should do blood tests to check your liver before and during treatment. If you develop liver problems during treatment with Verzenio, your health care provider may reduce your dose or stop your treatment. Tell your healthcare provider right away if you have any of the following signs or symptoms of liver problems:

Verzenio may cause blood clots in your veins, or in the arteries of your lungs. Verzenio may cause serious blood clots that have led to death. If you develop blood clots during treatment with Verzenio, your healthcare provider may tell you to temporarily stop taking it. Tell your healthcare provider right away if you have any of the following signs and symptoms of a blood clot:

Verzenio can harm your unborn baby. Use effective birth control (contraception) during treatment and for 3 weeks after the last dose of Verzenio and do not breastfeed during treatment with Verzenio and for at least 3 weeks after your last dose. Verzenio may affect the ability of males to father a child.

Common side effects

The most common side effects of Verzenio include:

These are not all the possible side effects of Verzenio.

Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before you use Verzenio, tell your healthcare provider about all your medical conditions, including:

What to avoid during treatment

Verzenio is a prescription medicine. For more information, call 1-800-545-5979.

This summary provides basic information about Verzenio but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Verzenio and how to take it. Your healthcare provider is the best person to help you decide if Verzenio is right for you.

AL CON BS 03MAR2023

Verzenio ® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.

Indication or Indications. Select to Expand. INDICATIONS Indication or Indications. Select to Expand.

INDICATIONS

Verzenio ® (ver-ZEN-ee-oh) is used to treat certain types of breast cancer known as HR+/HER2– (hormone receptor positive/human epidermal growth factor receptor 2 negative) breast cancer.

It is a medicine you can take if:

It is not known if Verzenio is safe and effective in children.

To speak to customer support:
Call (800) 545-5979

This site is intended for US residents aged 18 and older.

Verzenio ® is a registered trademark and Verzenio Continuous Care™ and Verzenio Vision™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.

Imodium ® is a registered trademark of Johnson & Johnson.

Other product/company names mentioned herein are the trademarks of their respective owners.